NDC 0904-7064

Atovaquone

Atovaquone

Atovaquone is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Major Pharmaceuticals. The primary component is Atovaquone.

Product ID0904-7064_31ad4347-790f-479f-a737-96a667380289
NDC0904-7064
Product TypeHuman Prescription Drug
Proprietary NameAtovaquone
Generic NameAtovaquone
Dosage FormSuspension
Route of AdministrationORAL
Marketing Start Date2018-10-11
Marketing CategoryANDA / ANDA
Application NumberANDA210692
Labeler NameMajor Pharmaceuticals
Substance NameATOVAQUONE
Active Ingredient Strength750 mg/5mL
Pharm ClassesAntimalarial [EPC],Antiprotozoal [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0904-7064-25

18 CUP in 1 CARTON (0904-7064-25) > 5 mL in 1 CUP (0904-7064-41)
Marketing Start Date2018-10-11
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Atovaquone" or generic name "Atovaquone"

NDCBrand NameGeneric Name
0121-0888AtovaquoneAtovaquone
0121-0898AtovaquoneAtovaquone
0121-1796AtovaquoneAtovaquone
0904-7064AtovaquoneAtovaquone
16714-900atovaquoneatovaquone
31722-629AtovaquoneAtovaquone
50268-086AtovaquoneAtovaquone
51407-642AtovaquoneAtovaquone
60687-534AtovaquoneAtovaquone
65162-693ATOVAQUONEATOVAQUONE
66689-062AtovaquoneAtovaquone
66993-062Atovaquoneatovaquone
68180-282AtovaquoneAtovaquone
68462-421atovaquoneatovaquone
70166-488AtovaquoneAtovaquone
10702-223Atovaquone Oral SuspensionAtovaquone
0173-0547MEPRONatovaquone
0173-0665MEPRONatovaquone

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.